Sichuan Huiyu Pharmaceutical Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Zhao Ding
Chief executive officer
CN¥1.5m
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 14.1yrs |
| CEO ownership | 26.9% |
| Management average tenure | no data |
| Board average tenure | 2.4yrs |
Recent management updates
Recent updates
Sichuan Huiyu Pharmaceutical's (SHSE:688553) Promising Earnings May Rest On Soft Foundations
Nov 02
Sichuan Huiyu Pharmaceutical Co., Ltd. (SHSE:688553) Stock Catapults 38% Though Its Price And Business Still Lag The Market
Oct 29Here's Why Sichuan Huiyu Pharmaceutical (SHSE:688553) Can Manage Its Debt Responsibly
Sep 29Sichuan Huiyu Pharmaceutical (SHSE:688553) Has A Pretty Healthy Balance Sheet
Jun 07Sichuan Huiyu Pharmaceutical Co., Ltd.'s (SHSE:688553) 33% Share Price Surge Not Quite Adding Up
Mar 07CEO
Zhao Ding (39 yo)
14.1yrs
Tenure
CN¥1,487,300
Compensation
Dr. Zhao Ding is Non- Executive Director of TYK Medicines, Inc from January 17, 2024 and servd as its Director since January 17, 2024 until January 8, 2024. Dr. Ding has experience in the pharmaceutical in...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman of the Board & GM | 14.1yrs | CN¥1.49m | 26.93% CN¥ 1.8b | |
| Director | 1.6yrs | CN¥590.60k | no data | |
| Director | 4.4yrs | no data | no data | |
| Supervisor | 4.7yrs | no data | no data | |
| Independent Director | less than a year | no data | no data | |
| Director | 2.4yrs | no data | no data | |
| Supervisor | 2.4yrs | no data | no data |
2.4yrs
Average Tenure
48yo
Average Age
Experienced Board: 688553's board of directors are not considered experienced ( 2.4 years average tenure), which suggests a new board.